Lung Cancer Screening Education for Head and Neck Cancer Survivors
(GUIAR Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Lung Cancer Screening Education for Head and Neck Cancer Survivors?
Research shows that low-dose computed tomography (LDCT) is effective for lung cancer screening in heavy smokers, improving patient-centered outcomes like quality of life and reducing anxiety. Effective communication and education about screening results, as seen in other studies, can enhance understanding and preparedness, potentially benefiting head and neck cancer survivors as well.12345
Is Lung Cancer Screening Education using Low-Dose Computed Tomography (LDCT) generally safe for humans?
How does lung cancer screening education for head and neck cancer survivors differ from other treatments?
This treatment is unique because it focuses on educating head and neck cancer survivors about lung cancer screening using low-dose computed tomography (LDCT), which is a non-invasive imaging technique that can detect lung cancer early in high-risk individuals. Unlike traditional treatments that directly target cancer, this approach emphasizes prevention and early detection through education and shared decision-making.1011121314
What is the purpose of this trial?
The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.
Research Team
Coral Olazagasti
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for Hispanic/LatinX adults over 18 who are head and neck cancer survivors, treated at least 5 years ago without recurrence. They must meet lung cancer screening criteria: either a history of heavy smoking or fitting the age/smoking profile per USPSTF21/NCCN guidelines. Pregnant/nursing individuals, those with recent lung imaging, active cancers, or less than a 20 pack-year smoking history cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Education and Survey
Participants receive intensive lung cancer screening and tobacco cessation education and complete survey questionnaires to assess awareness and perception of lung cancer screening recommendations
Follow-up
Participants are monitored for changes in awareness and perception of lung cancer screening recommendations and undergo early detection lung cancer screening
Treatment Details
Interventions
- Lung Cancer Screening Education
- Semi-Structured Interview
- Standard of Care Lung Cancer Screening Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
LUNGevity Foundation
Collaborator
National Cancer Institute (NCI)
Collaborator